| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/12/2011 | CN101239109B Externally-applied plaster for eliminating bony spur and preparation technique |
| 01/12/2011 | CN101234128B Paederus extraction liquid and application thereof |
| 01/12/2011 | CN101233836B High-efficiency organic circulating agricultural production system |
| 01/12/2011 | CN101214323B Orally-taken powder medicine and externally-applied plaster for treating angitis and preparation thereof |
| 01/12/2011 | CN101185695B Externally-applied traditional Chinese medicine for treating toothache |
| 01/12/2011 | CN101181498B Chinese medicine prescription for reducing blood pressure as well as manufacturing method |
| 01/12/2011 | CN101156900B A compound recipe traditional Chinese medicine for rapid treating fracture |
| 01/12/2011 | CN101152548B Medicine for treating gastropathy |
| 01/12/2011 | CN101129761B Health-preserving health care capsule for the elderly |
| 01/12/2011 | CN101088511B Simple method for ultralow temperature preservation of fish sperm |
| 01/12/2011 | CN101085107B Scorpion health-care lotion, health-care wine and preparation method |
| 01/11/2011 | US7868160 Compositions and methods for inhibiting expression of anti-apoptotic genes |
| 01/11/2011 | US7867982 administering to a primate(human) an immunogenic composition containing modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes to induce a CD8+T cell immune |
| 01/11/2011 | US7867973 comprises follistatin domain I; free of an amino acid sequence represented by formula (I): Cys-(X1)a-Cys-(X2)b-Cys-(X3)c-Cys-(X4)d-Cys-(X5)e-Cys-(X6)f-Cys-(X7)g-Cys-(X8)h-Cys-(X9)i-Cys [x=natural amino acids]; inhibiting GDF-8 activity without inhibiting activin activity |
| 01/11/2011 | US7867520 contains ash, calcium, and lactic acid in solid portion whey mineral; foods, beverages with reduced salt |
| 01/11/2011 | US7867519 Method for the acceleration or deceleration of angiogenesis using fibrin matrix formed from increased or decreased HMW/LMW fibrinogen ratio |
| 01/11/2011 | US7867499 VLP structure chemically coupled to a fragment of the A beta -1-42 peptide; Alzheimer's and Parkinson's disease |
| 01/11/2011 | US7867488 Use of dendritic cells (DCs) expressing interleukin 12 (IL-12) |
| 01/11/2011 | US7867483 using recombinant modified vaccinia virus Ankara (MVA) encoding a polypeptide comprising a human prostate-specific antigen (PSA) antigen and another encoding prostatic acid phosphatase (PAP); can induce B- and T-cell responses |
| 01/11/2011 | CA2364436C Lactic acid bacteria strains capable of preventing diarrhoea |
| 01/10/2011 | CA2709292A1 Oncolytic viruses and methods for treating neoplastic disorders |
| 01/06/2011 | WO2011002239A2 Microvesicles derived from nucleated, mammalian cells and use thereof |
| 01/06/2011 | WO2011002168A2 Use of novel lactobacillus helveticus or a culture thereof for preventing or treating dementia or cognitive dysfunction |
| 01/06/2011 | WO2011001181A1 Antimicrobial material |
| 01/06/2011 | WO2011000931A1 Biomass made of cyanobacteria having an antimycotic effect |
| 01/06/2011 | WO2011000820A2 Biological material suitable for the therapy of osteoarthrosis, ligament damage and for the treatment of joint disorders |
| 01/06/2011 | WO2011000621A1 Infant cereal comprising non-replicating probiotic microorganisms |
| 01/06/2011 | WO2011000620A1 Instant thickener comprising probiotics for hot or cold foods and beverages to be administered to dysphagic patients |
| 01/06/2011 | WO2011000516A2 Gamma globin therapy |
| 01/06/2011 | WO2011000124A1 Pharmaceutical composition including viable probiotic strains of lactobacillus spp. used for the prevention and recovery of individuals with urinary tract infections and immunocompromised individuals |
| 01/06/2011 | WO2011000123A1 Hydrocolloid plasters, including viable probiotic strains of lactobacillus spp. and used for various types of wounds, infected tissues, dry wounds and deep wounds |
| 01/06/2011 | WO2011000122A1 Formulation based on the synthesis of microspheres made from cross-linked natural gelatine, used as a carrier for strains of probiotic lactobacillus spp. for treating skin wounds and/or lesions |
| 01/06/2011 | WO2010130980A3 A fertilized, incubated avian egg or extract for the treatment of stress |
| 01/06/2011 | WO2010130785A3 Novel use of probiotics |
| 01/06/2011 | WO2010125196A3 Bacteriophages specific to pak and cha strains of pseudomonas aeruginosa and their applications |
| 01/06/2011 | WO2010109084A3 9h-pyrrolo[2,3-b: 5,4-c'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof |
| 01/06/2011 | WO2010099292A3 Biodegradable drug or other active delivery system |
| 01/06/2011 | WO2010096550A3 Lactobacillus supplement for alleviating type 1 diabetes |
| 01/06/2011 | WO2010070618A3 A microencapsulation process of sertoli cells, microcapsules obtained and their use for prevention and cure of type 1 diabetes mellitus |
| 01/06/2011 | US20110004304 Culturing retinal cells and tissues |
| 01/06/2011 | US20110004218 Process for the preparation of NACRE mechano-structured by mechanosynthesis, mechano-structured NACRE thus obtained and uses thereof |
| 01/06/2011 | US20110003388 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 01/06/2011 | US20110003358 Cultures of gfap+ nestin+ cells that differentiate to neurons |
| 01/06/2011 | US20110003307 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules |
| 01/06/2011 | US20110003009 Process for obtaining a rabbit skin comprising biological active substances |
| 01/06/2011 | US20110003008 Mesenchymal stem cell particles |
| 01/06/2011 | US20110003003 Magnetic cells for localizing delivery and tissue repair |
| 01/06/2011 | US20110002996 Acellular tissue matrices made from alpha-1,3-galactose-deficient tissue |
| 01/06/2011 | US20110002984 Formulations comprising exine shells |
| 01/06/2011 | US20110002981 MCPIP Protection Against Cardiac Dysfunction |
| 01/06/2011 | US20110002974 Random and non-random alkylene oxide polymer alloy compositions |
| 01/06/2011 | US20110002973 Materials and methods for minimally-invasive administration of a cell-containing flowable composition |
| 01/06/2011 | US20110002972 Neuroendocrine factors for treatment of degenerative diseases |
| 01/06/2011 | US20110002963 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers |
| 01/06/2011 | US20110002956 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/06/2011 | US20110002954 Rhoc-based immunotherapy |
| 01/06/2011 | US20110002946 Immunostimulatory Combinations |
| 01/06/2011 | US20110002943 Use of enterovirus for diagnostics, treatment and prevention of disease |
| 01/06/2011 | US20110002938 Hematopoietic cells expressing the protein krtcap3 and ligands for the protein krtcap3 |
| 01/06/2011 | US20110002930 Activated T Cells |
| 01/06/2011 | US20110002921 Combination cancer immunotherapy with co-stimulatory molecules |
| 01/06/2011 | US20110002920 Combination cancer immunotherapy with co-stimulatory molecules |
| 01/06/2011 | US20110002914 Hybrid tetnus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 01/06/2011 | US20110002912 Composition |
| 01/06/2011 | US20110002908 Treatment of a-galactosidase a deficiency |
| 01/06/2011 | US20110002907 Methods, Systems, Compositions And Dosage Forms For Diagnosing And Treating Male Infertility |
| 01/06/2011 | US20110002904 Synovial villi for use with tissue engineering |
| 01/06/2011 | US20110002903 Immunogenic control of tumours and tumour cells |
| 01/06/2011 | US20110002902 Inhibitor for blood phosphorus level elevation |
| 01/06/2011 | US20110002901 Bacterial strain having anti-allergic activity, and beverage, food and anti-allergic agent comprising cell of the bacterial strain |
| 01/06/2011 | US20110002900 Medium chain dicarboxylic acids, their derivates and metabolic disorders |
| 01/06/2011 | US20110002899 Lymph Nodes as a Site for Regeneration |
| 01/06/2011 | US20110002898 Vaccine compositions |
| 01/06/2011 | US20110002897 Directed differentiation of stem cells |
| 01/06/2011 | US20110002896 Methods and related compositions for reduction of fat |
| 01/06/2011 | US20110002895 Composition for autotransplantation or allotransplantation using dental pulp stem cell, and use of the composition |
| 01/06/2011 | US20110002894 Compositions and methods for treating and preventing heart tissue degeneration and uses thereof |
| 01/06/2011 | US20110002893 Diagnosis and treatment of congenital heart defects using nell1 |
| 01/06/2011 | US20110002892 Modular aptamar-regulated ribozymes |
| 01/06/2011 | US20110002891 Probiotic compositions and process thereof |
| 01/06/2011 | US20110002890 Treatment of tumors with genetically engineered herpes virus |
| 01/06/2011 | US20110002889 Cultures with Improved Phage Resistance |
| 01/06/2011 | US20110002881 Treatment and prophylaxis |
| 01/06/2011 | US20110002880 Material For Wound Healing and Skin Reconstruction |
| 01/06/2011 | US20110002854 Use of Francisella Tularensis For Prevention and Treatment of Allergic Airway Disorders |
| 01/06/2011 | US20110002852 Stem cells for use in locating and targeting tumor cells |
| 01/06/2011 | CA2765920A1 Antimicrobial material |
| 01/06/2011 | CA2763945A1 Biological material suitable for the therapy of osteoarthrosis, ligament damage and for the treatment of joint disorders |
| 01/06/2011 | CA2761672A1 Instant thickener comprising probiotics for hot or cold foods and beverages to be administered to dysphagic patients |
| 01/05/2011 | EP2270504A2 Techniques for growth and differentiation of human pluripotent stem cells |
| 01/05/2011 | EP2270192A1 Glycopeptide antibiotics |
| 01/05/2011 | EP2270191A1 Preparation of microbial oil containing polyunsaturated fatty acids |
| 01/05/2011 | EP2270170A1 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| 01/05/2011 | EP2270137A1 Method for producing cells having characteristic of hematopoietic stem cells/progenitor cells |
| 01/05/2011 | EP2270133A1 Method for obtaining a novel strain of bifidobacterium bifidum with activity against infection by helicobacter pylori |
| 01/05/2011 | EP2270131A1 Feline probiotic lactobacilli |
| 01/05/2011 | EP2269629A2 Compositions and methods for producing antigen-presenting cells |
| 01/05/2011 | EP2269628A2 Pancreas-specific proteins |
| 01/05/2011 | EP2269619A1 Methods and compositions concerning poxviruses and cancer |
| 01/05/2011 | EP2269618A1 An oncolytic vaccinia virus for use in combination with a chemotherapy for treating cancer. |